TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 187 filers reported holding TG THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.72 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $368 | -8.9% | 44,010 | +170.6% | 0.03% | -12.5% |
| Q2 2023 | $404 | -2.2% | 16,266 | -40.7% | 0.03% | +6.7% |
| Q1 2023 | $413 | -11.4% | 27,428 | -30.4% | 0.03% | -23.1% |
| Q4 2022 | $466 | -99.9% | 39,393 | -25.9% | 0.04% | +34.5% |
| Q3 2022 | $315,000 | +5.7% | 53,150 | -24.2% | 0.03% | +7.4% |
| Q2 2022 | $298,000 | +2.8% | 70,105 | +130.0% | 0.03% | +200.0% |
| Q1 2022 | $290,000 | +45.7% | 30,483 | +191.3% | 0.01% | +28.6% |
| Q4 2021 | $199,000 | – | 10,466 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 5,434,783 | $60,326,000 | 5.25% |
| RA Capital Management | 9,880,323 | $109,672,000 | 3.33% |
| BRIDGER MANAGEMENT, LLC | 1,907,492 | $21,173,000 | 1.53% |
| Eversept Partners, LP | 776,323 | $8,617,185 | 1.52% |
| Opaleye Management Inc. | 579,651 | $6,434,000 | 1.26% |
| Sofinnova Investments, Inc. | 811,292 | $9,006,000 | 0.65% |
| Ikarian Capital, LLC | 316,200 | $3,510,000 | 0.57% |
| ARMISTICE CAPITAL, LLC | 800,000 | $8,880,000 | 0.51% |
| 683 Capital Management, LLC | 398,271 | $4,421,000 | 0.51% |
| Frontier Wealth Management LLC | 196,750 | $2,184,000 | 0.35% |